Promisia Healthcare (PHL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
15 Jun, 2026Executive summary
Underlying EBITDAF rose 31% to $2.5 million for HY26, with operating revenue up 47% to $19.2 million year-over-year.
Group care occupancy improved from 87% in March to 90% in September, with Aldwins House reaching record occupancy above 90%.
New COO implemented operational improvements, unified systems, and facility health checks, driving rapid performance gains.
Upgraded FY26 underlying EBITDAF guidance to at least $6.1 million, representing over 45% year-on-year growth.
Strategic focus on performance, accountability, and cash generation, with leadership team delivering sustainable growth.
Financial highlights
Profit before income tax was $240,000, down from $5.45 million a year earlier due to a prior period non-cash bargain purchase gain.
Prior period included a $5.18 million non-cash bargain-purchase gain; current period includes $736,000 of non-cash imputed interest.
Net loss for the period was $49,000, compared to a profit of $5.8 million in the prior year.
Cash flow from operating activities increased to $2.8 million from $1.5 million year-over-year.
Outlook and guidance
Upgraded full-year underlying EBITDAF guidance to at least $6.1 million, exceeding initial guidance of 25% growth.
Second half focus on targeted growth, potential acquisition, and sustainable development of existing facilities.
Early-stage acquisition negotiations underway for large-scale integrated care and village facilities.
Each facility is targeting at least 95% occupancy in the second half.
Improving earnings, reduced leverage, and stronger cash flow position the company for sustainable growth.
Latest events from Promisia Healthcare
- Net profit after tax soared 318% to $6.8 million on 37% revenue growth and acquisition gains.PHL
H2 202515 Jun 2026 - Record revenue and profit growth driven by acquisitions and operational improvements.PHL
H1 202515 Jun 2026 - Revenue up 29%, EBITDAF up 58%, and new dividend policy based on free cash flow for FY27.PHL
H2 202627 May 2026 - Revenue up 37% and EBITDAF up 11.5%, with strong growth and expansion plans underway.PHL
AGM 2025 Presentation15 May 2026 - Promisia Healthcare targets double-digit earnings growth after a year of strong operational gains.PHL
AGM 2024 Presentation13 Jun 2025 - Cromwell acquisition and capital raise position Promisia for accelerated earnings growth.PHL
Investor Presentation13 Jun 2025